Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Dr Rajeev Jayadevan explains why a vaccine created for one Ebola strain may not necessarily protect against another and why ...

Doctors battling a rare strain of Ebola in central Africa will probably need to wait many months for a vaccine to be ready ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...

Researchers across the world are working on a hantavirus vaccine, though they say development is in the early stages and rollout could be years away.